SNPsig® VariPLEX™ is able to detect six key mutations of SARS-CoV-2 using PCR genotyping in under two hours Paris, France and Camberley, UK – 24 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that, further to the announcement on 2 February 2021, the Company will launch SNPsig®
Visit PageYear: 2021
Lancement de laboratoires de traitement mobiles pour le dépistage de la COVID-19
Paris, France et Camberley, Royaume-Uni – 17 mars 2021 –Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce l’expansion de son service VersaLab™ avec le lancement de laboratoires de traitement mobiles (MPL – Mobile Processing Laboratories) pour fournir des tests d’amplification en chaîne par polymérase rapides (PCR) sur site. Les tests seront
Visit PageLaunch of mobile processing laboratories to detect COVID-19
Paris, France and Camberley, UK – 17 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the expansion of its VersaLab™ service with the launch of mobile processing laboratories (MPL) to provide rapid turnaround polymerase chain reaction (PCR) testing on-site. Testing will be performed using mid-nose nasal swabs,
Visit Page